PortalPublikationenRepeated high dosage naloxone treatment without therapeutic ...

Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients.

Standard

Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients. / Naber, Dieter; Leibl, K.

in: Pharmacopsychiatria, Jahrgang 16, Nr. 2, 2, 1983, S. 43-45.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Naber, D & Leibl, K 1983, 'Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients.', Pharmacopsychiatria, Jg. 16, Nr. 2, 2, S. 43-45. <http://www.ncbi.nlm.nih.gov/pubmed/6346348?dopt=Citation>

APA

Naber, D., & Leibl, K. (1983). Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients. Pharmacopsychiatria, 16(2), 43-45. [2]. http://www.ncbi.nlm.nih.gov/pubmed/6346348?dopt=Citation

Vancouver

Naber D, Leibl K. Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients. Pharmacopsychiatria. 1983;16(2):43-45. 2.

Bibtex

@article{b1b9193848db476593cff50d75c32cef,
title = "Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients.",
abstract = "6 schizophrenic patients were treated in a cross-over design for 4 days each with 20 mg naloxone or placebo. No patient showed a significant change of his or her psychotic behaviour. This result is not in agreement with an antipsychotic action of the opiate antagonist.",
author = "Dieter Naber and K Leibl",
year = "1983",
language = "Deutsch",
volume = "16",
pages = "43--45",
number = "2",

}

RIS

TY - JOUR

T1 - Repeated high dosage naloxone treatment without therapeutic efficacy in schizophrenic patients.

AU - Naber, Dieter

AU - Leibl, K

PY - 1983

Y1 - 1983

N2 - 6 schizophrenic patients were treated in a cross-over design for 4 days each with 20 mg naloxone or placebo. No patient showed a significant change of his or her psychotic behaviour. This result is not in agreement with an antipsychotic action of the opiate antagonist.

AB - 6 schizophrenic patients were treated in a cross-over design for 4 days each with 20 mg naloxone or placebo. No patient showed a significant change of his or her psychotic behaviour. This result is not in agreement with an antipsychotic action of the opiate antagonist.

M3 - SCORING: Zeitschriftenaufsatz

VL - 16

SP - 43

EP - 45

IS - 2

M1 - 2

ER -